Business of Aesthetics

Top Story

Allergan reports Q2 net revenue increase

August 4, 2017

Allergan reported its second quarter 2017 operations performance, including total net revenues of $4 billion, which was a 9% increase from the same quarter a year earlier.

The revenue growth was driven by Botox (onabotulinumtoxinA) and the Juvéderm (injectible gel) collection, and the addition of Alloderm (tissue matrix) and CoolSculpting (cryolipolysis), according to a news release from Allergan.

Sienna Biopharmaceuticals closes initial public offering

August 2, 2017
Sienna Biopharmaceuticals announced the closing of its initial public offering of 4,983,333 shares of common stock at a public offering price of $15 per share. The…

Sientra, Silimed reach settlement on litigation on breast implant manufacturing

August 2, 2017
A settlement agreement was reached between Sientra Inc., a medical aesthetics corporation, and Silimed-Indústria de Implantes Ltda., the former contracted breast…

Galderma prescription program hits milestone

July 20, 2017
Galderma recently announced that its patient access program has surpassed 1,000,000 prescriptions. The Galderma CareConnect program is designed for accessibility and…
More Headlines »
Advertisement
Advertisement